Canine ReproVet
Conflict of Interest

Disclose, do not hide.

Scientific information is credible only if we know who produces it, who reviews it and where the money involved comes from. This page describes how Canine ReproVet Knowledge™ handles conflicts of interest.

Who discloses

Editorial roles subject to disclosure.

Founder & Scientific direction

Declare any economic or consulting interest with veterinary, pharmaceutical or reproductive-technology companies.

Editor-in-Chief and Associate Editors

Declare every commercial relationship, sponsorship, consultancy or relevant equity holding in their vertical domain.

External Reviewers

Before every review, they declare potential conflicts on the specific topic under review.

Guest Experts

Declare every funding source for their work related to the topic of their contribution.

Platform commitments

What the platform does, and what it will never do.

Public transparency

COI disclosures of board members are published next to their name, not hidden in an annex.

Editorial recusal

An editor with a COI on a topic recuses themselves from editorial decisions on it.

No content-level sponsorship

No SKO may be sponsored by a commercial company. Sponsorship, if any, is at platform level and disclosed publicly.

No pay-to-cite

No company can pay to be cited, mentioned or recommended in an SKO.

No hidden content

No commercial content may be presented as scientific. Sponsorships, if any, are labelled.

No favoured prescribing

No SKO privileges a brand, active ingredient or specific supplier beyond what the evidence justifies.

How we handle a disclosed COI

Four possible outcomes.

01

No impact

The disclosed interest does not touch the domain of the content: publication with visible disclosure.

02

Recusal

The editor recuses themselves from editorial decisions on that topic. Responsibility passes to another Associate Editor.

03

Strengthened peer review

If the COI is relevant but the contribution is valuable, at least two independent External Reviewers are added.

04

Rejection

If the COI is incompatible with editorial neutrality, the contribution is rejected.

A disclosure is not a flaw

The presence of a disclosed conflict of interest is not, in itself, a problem. The problem is failing to disclose it. We believe a real-world editorial board has relationships with industry: our mission is to make them visible, not to pretend they do not exist.

Related

Want to see the full governance framework?